spacer
home > ict > winter 2008 > we can be heroes
PUBLICATIONS
International Clinical Trials

We Can be Heroes

Describing the public health benefits of promoting patient participation, Kenneth Getz at the Tufts Center for the Study of Drug Development, James Kremidas at Eli Lilly and Company, Elizabeth Carfioli of Ogilvy Healthworld Consulting (US) and Rachael Butlin at Fast4wD Ogilvy (UK) challenge public perceptions of clinical trials

A GLOBAL PROBLEM

Clinical research is essential for developing treatments that improve public health. Without it, many medical advances that ease human suffering, offer better treatment options and even cure life-threatening illnesses would never have been introduced.

Despite the high importance of clinical research and the access to investigational new treatments that it affords, patient participation rates are low. As few as 10 per cent of eligible patients in the US participate in clinical trials (1) – a figure that is only slightly higher than other parts of the world, which sit at an overall participation rate of only six to eight per cent of eligible patients (2). Pharmaceutical companies are increasingly investing in communication programmes to ensure awareness and knowledge of the studies that they are conducting and, ultimately, to increase patient participation in clinical trials.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer

Kenneth A Getz is the chairman of CISCRP – a non-profit organisation that he founded to educate and raise public awareness of the clinical research enterprise – and a Senior Research fellow at the Tufts Center for the Study of Drug Development, where he studies R&D management and operating models, investigative sites, outsourcing and study volunteer trends and policies. A wellknown speaker, Ken has published over 150 articles and two books, and serves on a number of corporate and non-profit boards. Ken is also the founder and former CEO of CenterWatch, a leading publisher in the clinical trials industry.

Jim Kremidas leads the clinical trial patient recruitment and retention efforts at Eli Lilly and Company. His role focuses on predicting and accelerating the enrolment rates for all corporate studies. Jim is a member of the Steering Committee for the Center for Information and Study on Clinical Research Participation (CISCRP).

Elizabeth Carfioli has over 10 years of experience in the strategic planning and implementation of global patient recruitment and retention programmes, having worked for both agencies and sponsors. She is currently working for Ogilvy Healthworld Consulting, providing strategic counsel to clients on improving internal processes for enrolment acceleration.

Rachael Butlin is an Account Manager at Fast4wD Ogilvy, a specialised global patient recruitment and retention company. She has a business and marketing background, and has combined this experience with her knowledge of study stakeholder needs in outlining bespoke global programmes for a number of top pharmaceutical study sponsors. Her expertise spans numerous therapy areas including pain, oncology and mental health.

spacer
Kenneth A Getz
spacer
spacer
spacer
Jim Kremidas
spacer
spacer
spacer
Elizabeth Carfioli
spacer
spacer
spacer
Rachael Butlin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Injection vials for vaccines for protection against Covid-19

Düsseldorf, July 02, 2020 The vaccines under development to protect against Covid-19 are, like many other drugs, filled in so-called injection or vials made of type 1 borosilicate glass, also known as vials. The large worldwide demand for vials is met by the Gerresheimer Group's plants in Europe, America and Asia, where they are manufactured to high quality standards for customers in the pharmaceutical industry. The Company has already received initial orders for vials for drugs and vaccines against Covid-19.
More info >>

White Papers
 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement